Clinical Scorecard: Outcomes of Localized Full-Thickness Resection for Sessile Adenomas and cT1-2 Rectal Carcinoma: A Long-Term Analysis
At a Glance
Category
Detail
Condition
Sessile rectal adenomas and early-stage (cT1-2) rectal carcinoma
Key Mechanisms
Local full-thickness excision using transanal endoscopic microsurgery (TEM) or conventional transanal approach with curative intent
Target Population
Adult patients with benign adenomas unsuitable for endoscopic resection and stage I low-risk rectal cancer
Care Setting
High-volume academic center specializing in TEM with multidisciplinary team involvement
Key Highlights
TEM offers technical superiority over conventional transanal excision with lower recurrence rates and access to the entire rectum.
Patients with benign or low-risk pT1 lesions can be treated curatively with TEM alone without further treatment.
High-risk pT1 or pT2 lesions require shared decision-making regarding salvage surgery or adjuvant radiotherapy.
Guideline-Based Recommendations
Diagnosis
Detailed history and physical examination including digital rectal and rigid rectoscopic assessment.
Endorectal ultrasonography (ERUS) for staging neoplasms.
Full colonoscopy to exclude synchronous lesions and obtain biopsy samples.
For biopsy-proven adenocarcinoma: carcinoembryonic antigen (CEA), chest X-ray, abdominopelvic CT, and pelvic MRI (from 2003 onward).
Management
Full-thickness local excision with grossly negative 1-cm peripheral margins using TEM or conventional transanal approach for lowest lesions.
No routine suturing of the defect; decision based on surgeon preference.
For benign or low-risk pT1 lesions, TEM alone is curative with no further treatment.
For high-risk pT1 or pT2 lesions, offer either salvage radical surgery or adjuvant radiotherapy (5040 cGy in 28 fractions) after informed consent.
Monitoring & Follow-up
Postoperative follow-up with physical examination, rigid proctosigmoidoscopy, and ERUS at 4 weeks, then every 3 months for 2 years, every 6 months up to 5 years, and annually thereafter.
For malignant cases, include serum CEA level evaluation during follow-up.
Risks
Potential for local recurrence if excision margins are inadequate.
High-risk pathological features (poor differentiation, lymphatic/venous invasion, margin <1 mm) increase risk and necessitate additional treatment.
Patient & Prescribing Data
Patients with sessile rectal adenomas unsuitable for endoscopic resection and early-stage rectal cancer (cT1-2).
TEM is effective for curative local excision in low-risk lesions; high-risk lesions require additional therapy decisions balancing risks and benefits.
Clinical Best Practices
Select patients carefully based on tumor location (extraperitoneal rectum) and staging to ensure feasibility of complete local excision with negative margins.
Use multidisciplinary team discussions for cancer cases to guide treatment options.
Provide detailed patient counseling and obtain informed consent emphasizing benefits and risks of local excision versus radical surgery or radiotherapy.
Maintain prospective data collection and adhere to standardized follow-up protocols for early detection of recurrence.
Most people know that tobacco use is a major risk factor for oral and head and neck cancers. Some even understand that excessive alcohol consumption also ups the odds.
Analysis of 50 cases shows moderate diagnostic agreement between FNAC and histopathology and identifies pleomorphic adenoma as the most common neoplasm.
